A panel of experts debate whether the risk of using an immunosuppressant therapy outweighs the benefits for patients with progressing multiple sclerosis. Which drugs should be considered to be immunosuppressants? Which patients warrant such aggressive therapy? Watch the entire debate by registering at http://www.msimmunedebate.com/. CME no longer available.
Link to this comment:
All Comments (0)